The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Podcasts
Cyber Security: What You Need to Know
Cybersecurity vulnerabilities and intrusions pose risks for every hospital and its reputation.
Webcast
GPO or Local/Self Contracting Series: Introduction and the GPO Role – Part 1
Allen Archer, System Director of Supply Chain at Houston Healthcare, leads a thought-leader panel discussion about the role of GPOs within the chan
On-Demand Educational Webinars
Leading Change: Aligning Clinicians and Physicians Using Evidenced Based Data
Learn how to drive organizational and cultural improvements by utilizing cost, quality, and outcome data in the decision making process. This webinar…
On-Demand Educational Webinars
Organizing and Executing Supply Chain Costs through Clinical Variation and Reduction
Reducing variability in products, supplies, pharmaceuticals, and other cost drivers is key to achieving margins in Medicare payment. This webinar…
On-Demand Educational Webinars
Supplier Diversity: A Strategic Value Proposition
This webinar explains how supplier diversity can be a valuable investment toward sustainability. Presenters define supplier diversity and the…
e-Learning
The Process of Operationalizing Contracts to Support CQO